| Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant (NCT05103904) | Emory University | 2022-04-19 |
| Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV (NCT04514484) | National Cancer Institute (NCI) | 2021-11-22 |
| Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors (NCT04851119) | Children's Oncology Group | 2021-11-08 |
| Stereotactic Body Proton Radiotherapy for the Treatment of Liver Cancer (NCT04805788) | Mayo Clinic | 2021-08-24 |
| Ablation Plus Tislelizumab Versus Ablation Alone for Intrahepatic Recurrent Early Stage HCC (NCT04663035) | Ming Zhao | 2020-12-21 |
| IRX-2, Cyclophosphamide, and Nivolumab in Treating Patients With Recurrent or Metastatic and Refractory Liver Cancer (NCT03655002) | City of Hope Medical Center | 2019-02-21 |
| The Role Of Circulating Tumor Cells As Markers Of Advanced Disease And Prognosis In HCC (NCT04800497) | University of Milano Bicocca | 2019-02-07 |
| A Study of LioCyx in Patient With Recurrent HBV-related HCC Post Liver Transplantation (NCT03634683) | Lion TCR Pte. Ltd. | 2018-08-01 |
| Stereotactic Body Radiotherapy and Microwave Ablation for Recurrent Small Hepatocellular Carcinoma (NCT03609268) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2018-06-30 |
| TCR-Redirected T Cell Treatment in Patients With Recurrent HBV-related Hepatocellular Carcinoma Post Liver Transplantation (NCT04677088) | Xiaoshun He | 2018-03-29 |
| Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer (NCT03257761) | University of Southern California | 2018-02-07 |
| Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer (NCT03186898) | NRG Oncology | 2018-01-26 |
| Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors (NCT02867592) | National Cancer Institute (NCI) | 2017-05-18 |
| Transarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial Chemoembolization (NCT02762266) | Stanford University | 2016-02-27 |
| A Study of TCR-Redirected T Cell Infusion in Subject With Recurrent HBV-related HCC Post Liver Transplantation (NCT02719782) | Lion TCR Pte. Ltd. | 2015-07-02 |
| Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors (NCT02143401) | National Cancer Institute (NCI) | 2015-01-30 |
| Efficacy Analysis of Complete Laparoscopic Resection of Recurrent Hepatocellular Carcinoma (NCT02613156) | Sun Yat-sen University | 2014-06-01 |
| Comparison of Treatment of Recurrent HCC With Repeat Hepatectomy,and TACE With AFP Conversion (NCT02728219) | Eastern Hepatobiliary Surgery Hospital | 2012-05-01 |
| Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors (NCT01522820) | Roswell Park Cancer Institute | 2012-03-01 |
| Transarterial Chemoembolization (TACE) vs. CyberKnife for Recurrent Hepatocellular Carcinoma (HCC) (NCT01318200) | Accuray Incorporated | 2011-02-01 |
| Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma Recurrence (NCT02447679) | Chang Gung Memorial Hospital | 2010-08-01 |
| Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer (NCT01015833) | National Cancer Institute (NCI) | 2010-02-15 |